| Accession |
PRJCA028930 |
| Title |
An exploratory study to evaluate the safety and efficacy of famitinib malate combined with carrilizumab in the treatment of advanced thyroid cancer(Ahead-T210) |
| Relevance |
Medical |
| Data types |
Clinical data, imaging data, genetic data, etc
|
| Organisms |
Homo sapiens
|
| Description |
To evaluate the efficacy and safety of camrelizumab combined with famitinib in the treatment of advanced thyroid cancer |
| Sample scope |
Multiisolate |
| Release date |
2024-08-08 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| NA
|
|
NA
|
|
|
|
| Submitter |
luchongyang
chongyang
lu (chongyang.lu@hengrui.com)
|
| Organization |
Jiangsu Hengrui Pharmaceutical Co. LTD |
| Submission date |
2024-08-08 |
